ArticleClinical case reports2026
Clear Cell Sarcoma of the Kidney: A Kidney Malignancy in an 8-Year-Old Female Patient.
Article in Clinical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Clear Cell Sarcoma of the Kidney Case Reports Should Connect Renal-Origin Imaging With Staging, Treatment Rationale, and Follow-Up.Clinical case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Clear cell sarcoma of the kidney (CCSK) is a rare pediatric renal malignancy, accounting for 5% of primary kidney cancers, often mistaken for the Wilms tumor due to similar presentation and imaging but differing in histology and prognosis. An 8-year-old female presented with a painless right flank mass without hematuria or constitutional symptoms. Ultrasound revealed a heterogeneous echo-complex mass (7.29 × 8.79 × 7.96 cm) in the right kidney's upper pole, with cystic and solid components. Contrast-enhanced CT urogram confirmed a hetero-enhancing mass (7.78 × 9.04 × 8.04 cm) with hydronephrosis and a claw sign, indicating renal origin. Radical nephrectomy and histopathology confirmed CCSK, with chemotherapy initiated. CCSK requires differentiation from the Wilms tumor for appropriate management. Early ultrasound and CT urogram are critical for identifying malignant features, guiding radical nephrectomy to improve outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.